» Articles » PMID: 32123306

The Novel LncRNA BlackMamba Controls the Neoplastic Phenotype of ALK Anaplastic Large Cell Lymphoma by Regulating the DNA Helicase HELLS

Abstract

The molecular mechanisms leading to the transformation of anaplastic lymphoma kinase negative (ALK) anaplastic large cell lymphoma (ALCL) have been only in part elucidated. To identify new culprits which promote and drive ALCL, we performed a total transcriptome sequencing and discovered 1208 previously unknown intergenic long noncoding RNAs (lncRNAs), including 18 lncRNAs preferentially expressed in ALCL. We selected an unknown lncRNA, BlackMamba, with an ALK ALCL preferential expression, for molecular and functional studies. BlackMamba is a chromatin-associated lncRNA regulated by STAT3 via a canonical transcriptional signaling pathway. Knockdown experiments demonstrated that BlackMamba contributes to the pathogenesis of ALCL regulating cell growth and cell morphology. Mechanistically, BlackMamba interacts with the DNA helicase HELLS controlling its recruitment to the promoter regions of cell-architecture-related genes, fostering their expression. Collectively, these findings provide evidence of a previously unknown tumorigenic role of STAT3 via a lncRNA-DNA helicase axis and reveal an undiscovered role for lncRNA in the maintenance of the neoplastic phenotype of ALKALCL.

Citing Articles

Exploring the transcriptional cooperation between RUNX2 and its associated elncRNA RAIN.

Vitale E, Manicardi V, Gugnoni M, Torricelli F, Donati B, Muccioli S Cell Death Dis. 2024; 15(9):673.

PMID: 39271656 PMC: 11399121. DOI: 10.1038/s41419-024-07058-x.


HELLS regulates transcription in T-cell lymphomas by reducing unscheduled R-loops and by facilitating RNAPII progression.

Tameni A, Mallia S, Manicardi V, Donati B, Torricelli F, Vitale E Nucleic Acids Res. 2024; 52(11):6171-6182.

PMID: 38597676 PMC: 11194065. DOI: 10.1093/nar/gkae239.


Long Non-Coding RNA Signatures in Lymphopoiesis and Lymphoid Malignancies.

Baghdadi H, Heidari R, Zavvar M, Ahmadi N, Khomartash M, Vahidi M Noncoding RNA. 2023; 9(4).

PMID: 37624036 PMC: 10458434. DOI: 10.3390/ncrna9040044.


Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphoma.

Mularoni V, Donati B, Tameni A, Manicardi V, Reggiani F, Sauta E Haematologica. 2023; 108(12):3333-3346.

PMID: 37381763 PMC: 10690924. DOI: 10.3324/haematol.2022.282552.


Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies.

Zhao A, Zhou H, Yang J, Li M, Niu T Signal Transduct Target Ther. 2023; 8(1):71.

PMID: 36797244 PMC: 9935927. DOI: 10.1038/s41392-023-01342-6.


References
1.
Swerdlow S, Campo E, Pileri S, Lee Harris N, Stein H, Siebert R . The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127(20):2375-90. PMC: 4874220. DOI: 10.1182/blood-2016-01-643569. View

2.
Hapgood G, Savage K . The biology and management of systemic anaplastic large cell lymphoma. Blood. 2015; 126(1):17-25. DOI: 10.1182/blood-2014-10-567461. View

3.
Crescenzo R, Abate F, Lasorsa E, Tabbo F, Gaudiano M, Chiesa N . Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma. Cancer Cell. 2015; 27(4):516-32. PMC: 5898430. DOI: 10.1016/j.ccell.2015.03.006. View

4.
Parrilla Castellar E, Jaffe E, Said J, Swerdlow S, Ketterling R, Knudson R . ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. Blood. 2014; 124(9):1473-80. PMC: 4148769. DOI: 10.1182/blood-2014-04-571091. View

5.
Ferreri A, Govi S, Pileri S, Savage K . Anaplastic large cell lymphoma, ALK-negative. Crit Rev Oncol Hematol. 2012; 85(2):206-15. DOI: 10.1016/j.critrevonc.2012.06.004. View